Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
arsenic trioxide
i
Other names:
NSC-706363, As2O3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
Generic mfg.
Drug class:
Apoptosis stimulant
Related drugs:
‹
lurbinectedin (11)
STA-4783 (5)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
lurbinectedin (11)
STA-4783 (5)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
quaratusugene ozeplasmid (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
Chr t(15;17)
Acute Promyelocytic Leukemia
Chr t(15;17)
Acute Promyelocytic Leukemia
arsenic trioxide
Sensitive: A1 - Approval
arsenic trioxide
Sensitive
:
A1
arsenic trioxide
Sensitive: A1 - Approval
arsenic trioxide
Sensitive
:
A1
PML-RARA fusion
Acute Promyelocytic Leukemia
PML-RARA fusion
Acute Promyelocytic Leukemia
arsenic trioxide
Sensitive: A1 - Approval
arsenic trioxide
Sensitive
:
A1
arsenic trioxide
Sensitive: A1 - Approval
arsenic trioxide
Sensitive
:
A1
PML-RARA fusion
Acute Promyelocytic Leukemia
PML-RARA fusion
Acute Promyelocytic Leukemia
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression
Acute Promyelocytic Leukemia
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression
Acute Promyelocytic Leukemia
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive
:
C4
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive
:
C4
NUP98-RARG fusion
Acute Myelogenous Leukemia
NUP98-RARG fusion
Acute Myelogenous Leukemia
arsenic trioxide
Sensitive: C4 – Case Studies
arsenic trioxide
Sensitive
:
C4
arsenic trioxide
Sensitive: C4 – Case Studies
arsenic trioxide
Sensitive
:
C4
CLTC-ALK fusion
Diffuse Large B Cell Lymphoma
CLTC-ALK fusion
Diffuse Large B Cell Lymphoma
arsenic trioxide
Sensitive: D – Preclinical
arsenic trioxide
Sensitive
:
D
arsenic trioxide
Sensitive: D – Preclinical
arsenic trioxide
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login